EOD Regional Nodes

Notes

**Note 1:** Code only regional nodes and nodes, NOS, in this field. Distant nodes are coded in EOD Mets. **Note 2:** Code 300 if there are satellite(s) or in-transit metastasis without regional lymph node involvement. Code 500 or 700 (based on number of nodes involved) if both satellite nodules/in-transit metastases and regional lymph nodes are present. **Note 3:** Bilateral or contralateral nodes are classified as regional nodes for head, neck, and truncal tumors with bidirectional drainage to primary nodal basins, as shown on lymphoscintigraphy. Truncal tumors may also drain to both cephalad and caudal primary nodal basins as shown on lymphoscintigraphy. * Clinical assessment of bilateral/contralateral or cephalad/caudal regional nodal involvement is required for tumors where lymphoscintigraphy is not performed **Note 4:** Contiguous or secondary nodal basins are the next nodal drainage basins beyond the primary nodal basins and are coded as regional nodes. **Note 5:** Regional lymph nodes for skin **SKIN (C440-C449)** Single, Multiple, Ipsilateral, Bilateral or Contralateral lymph nodes **Head and Neck** All subsites: Cervical **Lip** Facial (buccinator, buccal, nasolabial) Mandibular (submandibular, submaxillary, NOS) Parotid (infra-auricular, preauricular, NOS) Submental **External ear/auditory canal** Mastoid (post-/retro-auricular) (occipital) Preauricular **Face, Other (cheek, chin, forehead, jaw, nose and temple)** Facial (buccinator, buccal, nasolabial) Mandibular (submandibular, submaxillary, NOS) Parotid (infra-auricular, preauricular, NOS) Submental **Scalp** Mastoid (post-/retro-auricular) (occipital) Parotid (infra-auricular, preauricular, NOS) Spinal accessory (posterior cervical) **Neck** Axillary Mandibular, NOS Mastoid (post-/retro-auricular) (occipital) Parotid (infra-auricular, preauricular, NOS) Spinal accessory (posterior cervical) Submental Supraclavicular (transverse cervical) **Upper Trunk** Axillary Cervical Internal mammary (parasternal) Supraclavicular (transverse cervical) **Lower Trunk** Femoral (superficial inguinal) **Arm/Shoulder** Axillary Epitrochlear for hand/forearm Spinal accessory for shoulder **Leg/Hip** Femoral (superficial inguinal) Popliteal for heel and calf **VULVA (C510-C512, C518-C519)** Deep inguinal, NOS Femoral Inguinal, NOS Inguinofemoral (groin) Node of Cloquet or Rosenmuller (highest deep inguinal) Superficial inguinal (femoral) **PENIS (C600-C602, C608-C609)** Iliac, NOS External Internal (hypogastric, obturator) Inguinal, NOS Node of Cloquet or Rosenmuller (highest deep inguinal) Superficial [femoral] Pelvic, NOS **SCROTUM (C632)** Iliac, NOS External Internal (hypogastric), NOS: Obturator Inguinal, NOS Deep inguinal, NOS Node of Cloquet or Rosenmuller (highest deep inguinal) Superficial inguinal (femoral) **Note 6:** See the schema specific anatomical sites for the list of specific regional nodes. * C000-C006, C008-C009 Lip * C210 Anus * C300 Nasal Cavity * C500 Breast
Code Description SS2018 N
000 No regional lymph node involvement NONE
100 One clinically occult (detected by SLN biopsy) - WITHOUT in-transit, satellite, and/or microsatellite metastasis RN
200 One clinically detected node - WITHOUT in-transit, satellite, and/or microsatellite metastasis RN
300 No clinically occult or detected nodes - WITH in-transit, satellite, and/or microsatellite metastasis + WITH or WITHOUT involved lymph nodes RN
350 One involved node UNKNOWN how detected - WITHOUT in-transit, satellite, and/or microsatellite metastasis RN
400 Two or three clinically occult (detected by SLN biopsy) - WITHOUT in-transit, satellite, and/or microsatellite metastasis RN
450 Two or three involved nodes WITH 1 or greater clinically detected - WITHOUT in-transit, satellite, and/or microsatellite metastasis RN
500 One clinically occult or detected node - WITH in-transit, satellite, and/or microsatellite metastasis RN
550 Two or three involved nodes UNKNOWN how detected - WITHOUT in-transit, satellite, and/or microsatellite metastasis RN
600 Four or more clinically occult (detected by SLN biopsy) - WITHOUT in-transit, satellite, and/or microsatellite metastasis RN
650 Four or more positive WITH 1 or greater clinically detected - AND/OR matted nodes + WITHOUT in-transit, satellite, and/or microsatellite metastasis RN
700 Two or more clinically occult or detected - AND/OR matted nodes + WITH in-transit, satellite, and/or microsatellite metastasis RN
750 Four or more involved nodes UNKNOWN how detected - UNKNOWN if matted nodes + WITHOUT in-transit, satellite, and/or microsatellite metastasis RN
800 Regional lymph node(s), NOS Lymph node(s), NOS RN
999 Unknown; regional lymph node(s) not stated Regional lymph node(s) cannot be assessed Not documented in patient record Death Certificate Only U
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998 (2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001. (3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL) (4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30 (5) Gershenwald, J.E., Scolyer, R.A., et al. **Melanoma of the Skin**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 563-585